Literature DB >> 2910812

A gene for high urinary kallikrein may protect against hypertension in Utah kindreds.

T D Berry1, S J Hasstedt, S C Hunt, L L Wu, J B Smith, K O Ash, H Kuida, R R Williams.   

Abstract

The inheritance of 12-hour overnight total urinary kallikrein excretion and its association with family history of essential hypertension were studied in 405 normotensive adults and 391 youths in 57 Utah pedigrees. Total urinary kallikrein excretion was highly familial with 51% of the total variance attributable to a dominant allele for high total urinary kallikrein excretion and 27% attributable to the combined effects of polygenes and shared family environment. An estimated 28% of the population has one or two copies of the dominant allele for high total urinary kallikrein excretion (2.3 SD units higher than the low homozygotes). About 83% of the population could be assigned to one of the two genotypic populations. Individuals with the high total urinary kallikrein excretion genotype were significantly less likely to have one or two hypertensive parents (relative odds = 0.56, p = 0.042). We conclude that a dominant allele expressed as high total urinary kallikrein excretion may be associated with decreased risk of essential hypertension. Further studies should be performed to confirm this finding and to test for interactions between this apparently protective gene and other genetic and environmental determinants of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910812     DOI: 10.1161/01.hyp.13.1.3

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  The influence of age, sex and race on salivary kallikrein levels in human mixed saliva.

Authors:  J W Jenzano; S L Hogan; R L Lundblad
Journal:  Agents Actions       Date:  1992-01

Review 2.  Tissue kallikreins structure, regulation, and participation in mammalian physiology and disease.

Authors:  H S Margolius
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Somatic cell gene therapy for a trait as complex as hypertension?

Authors:  J A Martinez; D T O'Connor
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample.

Authors:  L Pérusse; P P Moll; C F Sing
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

5.  Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.

Authors:  Michel Azizi; Pierre Boutouyrie; Alvine Bissery; Mohsen Agharazii; Francis Verbeke; Nora Stern; Alessandra Bura-Rivière; Stéphane Laurent; François Alhenc-Gelas; Xavier Jeunemaitre
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice.

Authors:  P Meneton; M Bloch-Faure; A A Hagege; H Ruetten; W Huang; S Bergaya; D Ceiler; D Gehring; I Martins; G Salmon; C M Boulanger; J Nussberger; B Crozatier; J M Gasc; D Heudes; P Bruneval; T Doetschman; J Ménard; F Alhenc-Gelas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

7.  Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system.

Authors:  Laura P Svetkey; Emily L Harris; Eden Martin; William M Vollmer; Gayle T Meltesen; Vincent Ricchiuti; Gordon Williams; Lawrence J Appel; George A Bray; Thomas J Moore; Michelle P Winn; Paul R Conlin
Journal:  Am J Hypertens       Date:  2010-11-18       Impact factor: 2.689

8.  Dexamethasone induced alterations in the levels of proteases involved in blood pressure homeostasis and blood coagulation in rats.

Authors:  S Rajashree; R Puvanakrishnan
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

9.  Chronic kinin receptor blockade induces hypertension in deoxycorticosterone-treated rats.

Authors:  P Madeddu; V Anania; P P Parpaglia; M P Demontis; M V Varoni; M C Fattaccio; N Glorioso
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

Review 10.  Genetic determinants of human hypertension.

Authors:  R P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.